{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T01:33:34Z","timestamp":1785375214055,"version":"3.55.0"},"reference-count":33,"publisher":"American Society of Hematology","issue":"14","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,7,27]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Data addressing prognostication in patients with HIV related Burkitt lymphoma (HIV-BL) currently treated remain scarce. We present an international analysis of 249 (United States: 140; United Kingdom: 109) patients with HIV-BL treated from 2008 to 2019 aiming to identify prognostic factors and outcomes. With a median follow up of 4.5 years, the 3-year progression-free survival (PFS) and overall survival (OS) were 61% (95% confidence interval [CI] 55% to 67%) and 66% (95%CI 59% to 71%), respectively, with similar results in both countries. Patients with baseline central nervous system (CNS) involvement had shorter 3-year PFS (36%) compared to patients without CNS involvement (69%; P &amp;lt; .001) independent of frontline treatment. The incidence of CNS recurrence at 3 years across all treatments was 11% with a higher incidence observed after dose-adjusted infusional etoposide, doxorubicin, vincristine, prednisone, cyclophosphamide (DA-EPOCH) (subdistribution hazard ratio: 2.52; P = .03 vs other regimens) without difference by CD4 count 100\/mm3. In multivariate models, factors independently associated with inferior PFS were Eastern Cooperative Oncology Group (ECOG) performance status 2-4 (hazard ratio [HR] 1.87; P = .007), baseline CNS involvement (HR 1.70; P = .023), lactate dehydrogenase &amp;gt;5 upper limit of normal (HR 2.09; P &amp;lt; .001); and &amp;gt;1 extranodal sites (HR 1.58; P = .043). The same variables were significant in multivariate models for OS. Adjusting for these prognostic factors, treatment with cyclophosphamide, vincristine, doxorubicin, and high-dose methotrexate, ifosfamide, etoposide, and high-dose cytarabine (CODOX-M\/IVAC) was associated with longer PFS (adjusted HR [aHR] 0.45; P = .005) and OS (aHR 0.44; P = .007). Remarkably, HIV features no longer influence prognosis in contemporaneously treated HIV-BL.<\/jats:p>","DOI":"10.1182\/bloodadvances.2021004458","type":"journal-article","created":{"date-parts":[[2021,7,20]],"date-time":"2021-07-20T16:01:53Z","timestamp":1626796913000},"page":"2852-2862","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":47,"title":["HIV-associated Burkitt lymphoma: outcomes from a US-UK collaborative analysis"],"prefix":"10.1182","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2690-3377","authenticated-orcid":false,"given":"Juan Pablo","family":"Alderuccio","sequence":"first","affiliation":[{"name":"Sylvester Comprehensive Cancer Center, Miller School of Medicine, University of Miami, Miami, FL;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam J.","family":"Olszewski","sequence":"additional","affiliation":[{"name":"Division of Hematology\/Oncology, Brown University, Providence, RI;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew M.","family":"Evens","sequence":"additional","affiliation":[{"name":"Rutgers Cancer Institute of New Jersey, New Brunswick, NJ;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graham P.","family":"Collins","sequence":"additional","affiliation":[{"name":"NIHR Oxford Biomedical Research Centre, Oxford Cancer and Haematology Centre, Churchill Hospital, Oxford;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexey V.","family":"Danilov","sequence":"additional","affiliation":[{"name":"City of Hope National Medical Center, Duarte, CA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4077-6351","authenticated-orcid":false,"given":"Mark","family":"Bower","sequence":"additional","affiliation":[{"name":"National Centre for HIV Malignancy, Chelsea and Westminster Hospital, London, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepa","family":"Jagadeesh","sequence":"additional","affiliation":[{"name":"Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8644-1813","authenticated-orcid":false,"given":"Catherine","family":"Zhu","sequence":"additional","affiliation":[{"name":"University College London Hospital, London, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Sperling","sequence":"additional","affiliation":[{"name":"Division of Medical Oncology, University of Washington\/Fred Hutchinson Cancer Research Center, Seattle, WA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1835-2998","authenticated-orcid":false,"given":"Seo-Hyun","family":"Kim","sequence":"additional","affiliation":[{"name":"Rush University Medical Center, Chicago, IL;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan","family":"Vaca","sequence":"additional","affiliation":[{"name":"Penn State Cancer Institute, College of Medicine, Penn State University, Hershey, PA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Wei","sequence":"additional","affiliation":[{"name":"Rutgers Cancer Institute of New Jersey, New Brunswick, NJ;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5731-8226","authenticated-orcid":false,"given":"Suchitra","family":"Sundaram","sequence":"additional","affiliation":[{"name":"Roswell Park Comprehensive Cancer Center, Buffalo, NY;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nishitha","family":"Reddy","sequence":"additional","affiliation":[{"name":"Vanderbilt University Medical Center, Nashville, TN;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessia","family":"Dalla Pria","sequence":"additional","affiliation":[{"name":"National Centre for HIV Malignancy, Chelsea and Westminster Hospital, London, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8456-0889","authenticated-orcid":false,"given":"Christopher","family":"D\u2019Angelo","sequence":"additional","affiliation":[{"name":"Carbone Cancer Center, University of Wisconsin, Madison, WI;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umar","family":"Farooq","sequence":"additional","affiliation":[{"name":"Division of Hematology, Oncology, and Blood & Marrow Transplantation, University of Iowa, Iowa City, IA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0773-1829","authenticated-orcid":false,"given":"David A.","family":"Bond","sequence":"additional","affiliation":[{"name":"James Cancer Center, The Ohio State University Hospital, Columbus, OH;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Berg","sequence":"additional","affiliation":[{"name":"Loyola University Medical Center, Maywood, IL;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael C.","family":"Churnetski","sequence":"additional","affiliation":[{"name":"Winship Cancer Institute, Emory University Medical Center, Atlanta, GA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1943-4442","authenticated-orcid":false,"given":"Amandeep","family":"Godara","sequence":"additional","affiliation":[{"name":"Tufts Medical Center, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8259-4129","authenticated-orcid":false,"given":"Nadia","family":"Khan","sequence":"additional","affiliation":[{"name":"Fox Chase Cancer Center, Philadelphia, PA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun Kyong","family":"Choi","sequence":"additional","affiliation":[{"name":"New York University (NYU) Cancer Institute, School of Medicine, NYU, New York, NY;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shireen","family":"Kassam","sequence":"additional","affiliation":[{"name":"King\u2019s College Hospital, London, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2787-3867","authenticated-orcid":false,"given":"Maryam","family":"Yazdy","sequence":"additional","affiliation":[{"name":"Lombardi Comprehensive Cancer Center, Georgetown University Hospital, Washington, DC;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Rabinovich","sequence":"additional","affiliation":[{"name":"Division of Hematology\/Oncology, University of Illinois at Chicago, Chicago, IL;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2844-1612","authenticated-orcid":false,"given":"Frank A.","family":"Post","sequence":"additional","affiliation":[{"name":"King\u2019s College Hospital, London, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1903-9170","authenticated-orcid":false,"given":"Gaurav","family":"Varma","sequence":"additional","affiliation":[{"name":"Weill Cornell Medicine, New York-Presbyterian Hospital, New York, NY;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reem","family":"Karmali","sequence":"additional","affiliation":[{"name":"Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, IL;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5105-0564","authenticated-orcid":false,"given":"Madelyn","family":"Burkart","sequence":"additional","affiliation":[{"name":"Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, IL;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Martin","sequence":"additional","affiliation":[{"name":"Weill Cornell Medicine, New York-Presbyterian Hospital, New York, NY;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert","family":"Ren","sequence":"additional","affiliation":[{"name":"Division of Hematology\/Oncology, University of Illinois at Chicago, Chicago, IL;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayushi","family":"Chauhan","sequence":"additional","affiliation":[{"name":"Lombardi Comprehensive Cancer Center, Georgetown University Hospital, Washington, DC;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1116-3246","authenticated-orcid":false,"given":"Catherine","family":"Diefenbach","sequence":"additional","affiliation":[{"name":"New York University (NYU) Cancer Institute, School of Medicine, NYU, New York, NY;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allandria","family":"Straker-Edwards","sequence":"additional","affiliation":[{"name":"Fox Chase Cancer Center, Philadelphia, PA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Klein","sequence":"additional","affiliation":[{"name":"Tufts Medical Center, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristie A.","family":"Blum","sequence":"additional","affiliation":[{"name":"Winship Cancer Institute, Emory University Medical Center, Atlanta, GA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsten Marie","family":"Boughan","sequence":"additional","affiliation":[{"name":"University Hospitals Seidman Cancer Center, Cleveland, OH;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6992-4883","authenticated-orcid":false,"given":"Agrima","family":"Mian","sequence":"additional","affiliation":[{"name":"Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3872-0615","authenticated-orcid":false,"given":"Bradley M.","family":"Haverkos","sequence":"additional","affiliation":[{"name":"Division of Hematology, University of Colorado, Denver, CO;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor M.","family":"Orellana-Noia","sequence":"additional","affiliation":[{"name":"Winship Cancer Institute, Emory University Medical Center, Atlanta, GA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vaishalee P.","family":"Kenkre","sequence":"additional","affiliation":[{"name":"Carbone Cancer Center, University of Wisconsin, Madison, WI;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7591-2069","authenticated-orcid":false,"given":"Adam","family":"Zayac","sequence":"additional","affiliation":[{"name":"Division of Hematology\/Oncology, Brown University, Providence, RI;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4774-806X","authenticated-orcid":false,"given":"Seth M.","family":"Maliske","sequence":"additional","affiliation":[{"name":"Division of Hematology, Oncology, and Blood & Marrow Transplantation, University of Iowa, Iowa City, IA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8216-3457","authenticated-orcid":false,"given":"Narendranath","family":"Epperla","sequence":"additional","affiliation":[{"name":"James Cancer Center, The Ohio State University Hospital, Columbus, OH;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Caimi","sequence":"additional","affiliation":[{"name":"University Hospitals Seidman Cancer Center, Cleveland, OH;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott E.","family":"Smith","sequence":"additional","affiliation":[{"name":"Loyola University Medical Center, Maywood, IL;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manali","family":"Kamdar","sequence":"additional","affiliation":[{"name":"Division of Hematology, University of Colorado, Denver, CO;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parameswaran","family":"Venugopal","sequence":"additional","affiliation":[{"name":"Rush University Medical Center, Chicago, IL;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatyana A.","family":"Feldman","sequence":"additional","affiliation":[{"name":"John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Rector","sequence":"additional","affiliation":[{"name":"John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5354-7593","authenticated-orcid":false,"given":"Stephen D.","family":"Smith","sequence":"additional","affiliation":[{"name":"Division of Medical Oncology, University of Washington\/Fred Hutchinson Cancer Research Center, Seattle, WA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrzej","family":"Stadnik","sequence":"additional","affiliation":[{"name":"Knight Cancer Institute, Oregon Health & Science University, Portland, OR;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig A.","family":"Portell","sequence":"additional","affiliation":[{"name":"University of Virginia Cancer Center, Charlottesville, VA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Lin","sequence":"additional","affiliation":[{"name":"Rutgers Cancer Institute of New Jersey, New Brunswick, NJ;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9859-151X","authenticated-orcid":false,"given":"Seema","family":"Naik","sequence":"additional","affiliation":[{"name":"Penn State Cancer Institute, College of Medicine, Penn State University, Hershey, PA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Montoto","sequence":"additional","affiliation":[{"name":"St Bartholomew's and The Royal London NHS Trust, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9346-9013","authenticated-orcid":false,"given":"Izidore S.","family":"Lossos","sequence":"additional","affiliation":[{"name":"Sylvester Comprehensive Cancer Center, Miller School of Medicine, University of Miami, Miami, FL;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate","family":"Cwynarski","sequence":"additional","affiliation":[{"name":"University College London Hospital, London, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2021,7,20]]},"reference":[{"issue":"9","key":"2021072015341282800_B1","doi-asserted-by":"crossref","first-page":"e641","DOI":"10.1016\/S2352-3018(20)30118-1","article-title":"Epidemiology of haematological malignancies in people living with HIV","volume":"7","author":"Kimani","year":"2020","journal-title":"Lancet HIV."},{"issue":"15","key":"2021072015341282800_B2","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1097\/QAD.0000000000000428","article-title":"Risk of non-Hodgkin lymphoma subtypes in HIV-infected people during the HAART era: a population-based study","volume":"28","author":"Gibson","year":"2014","journal-title":"AIDS."},{"issue":"16","key":"2021072015341282800_B3","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1093\/jnci\/djt158","article-title":"Temporal trends in presentation and survival for HIV-associated lymphoma in the antiretroviral therapy era","volume":"105","author":"Gopal","year":"2013","journal-title":"J Natl Cancer Inst."},{"issue":"17","key":"2021072015341282800_B4","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1002\/cncr.30112","article-title":"Human immunodeficiency virus-associated lymphomas in the antiretroviral therapy era: analysis of the National Cancer Data Base","volume":"122","author":"Olszewski","year":"2016","journal-title":"Cancer."},{"issue":"4","key":"2021072015341282800_B5","doi-asserted-by":"crossref","first-page":"e240","DOI":"10.1016\/S2352-3018(18)30360-6","article-title":"Association of immunosuppression and HIV viraemia with non-Hodgkin lymphoma risk overall and by subtype in people living with HIV in Canada and the USA: a multicentre cohort study","volume":"6","author":"Hern\u00e1ndez-Ram\u00edrez","year":"2019","journal-title":"Lancet HIV."},{"issue":"25","key":"2021072015341282800_B6","doi-asserted-by":"crossref","first-page":"5600","DOI":"10.1182\/blood-2010-03-275917","article-title":"AIDS-related Burkitt lymphoma in the United States: what do age and CD4 lymphocyte patterns tell us about etiology and\/or biology?","volume":"116","author":"Guech-Ongey","year":"2010","journal-title":"Blood."},{"issue":"8","key":"2021072015341282800_B7","doi-asserted-by":"crossref","first-page":"e594","DOI":"10.1016\/S2352-3026(20)30126-5","article-title":"HIV-associated Burkitt lymphoma","volume":"7","author":"Atallah-Yunes","year":"2020","journal-title":"Lancet Haematol."},{"issue":"1","key":"2021072015341282800_B8","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1002\/cncr.23522","article-title":"High-dose chemotherapy and immunotherapy in adult Burkitt lymphoma: comparison of results in human immunodeficiency virus-infected and noninfected patients","volume":"113","author":"Oriol","year":"2008","journal-title":"Cancer."},{"issue":"6","key":"2021072015341282800_B9","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1111\/bjh.13221","article-title":"Survival of AIDS-related diffuse large B-cell lymphoma, Burkitt lymphoma, and plasmablastic lymphoma in the German HIV Lymphoma Cohort","volume":"168","author":"Schommers","year":"2015","journal-title":"Br J Haematol."},{"issue":"2","key":"2021072015341282800_B10","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1182\/blood-2015-01-623900","article-title":"AMC 048: modified CODOX-M\/IVAC-rituximab is safe and effective for HIV-associated Burkitt lymphoma","volume":"126","author":"Noy","year":"2015","journal-title":"Blood."},{"issue":"8","key":"2021072015341282800_B11","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1097\/QAD.0000000000000623","article-title":"Adding rituximab to CODOX-M\/IVAC chemotherapy in the treatment of HIV-associated Burkitt lymphoma is safe when used with concurrent combination antiretroviral therapy","volume":"29","author":"Alwan","year":"2015","journal-title":"AIDS."},{"issue":"6","key":"2021072015341282800_B12","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1097\/QAD.0b013e3283301578","article-title":"Excellent immunological recovery following CODOX-M\/IVAC, an effective intensive chemotherapy for HIV-associated Burkitt\u2019s lymphoma","volume":"24","author":"Montoto","year":"2010","journal-title":"AIDS."},{"issue":"5","key":"2021072015341282800_B13","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1002\/cncr.10365","article-title":"Hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone and highly active antiretroviral therapy for patients with acquired immunodeficiency syndrome-related Burkitt lymphoma\/leukemia","volume":"94","author":"Cortes","year":"2002","journal-title":"Cancer."},{"issue":"8","key":"2021072015341282800_B14","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1093\/annonc\/mdq677","article-title":"Evaluation of the addition of rituximab to CODOX-M\/IVAC for Burkitt\u2019s lymphoma: a retrospective analysis","volume":"22","author":"Barnes","year":"2011","journal-title":"Ann Oncol."},{"issue":"22","key":"2021072015341282800_B15","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1200\/JCO.20.00303","article-title":"Multicenter study of risk-adapted therapy with dose-adjusted EPOCH-R in adults with untreated Burkitt lymphoma","volume":"38","author":"Roschewski","year":"2020","journal-title":"J Clin Oncol."},{"issue":"3","key":"2021072015341282800_B16","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1182\/blood.2020006926","article-title":"Burkitt lymphoma in the modern era: real-world outcomes and prognostication across 30 US cancer centers","volume":"137","author":"Evens","year":"2021","journal-title":"Blood."},{"key":"2021072015341282800_B17","volume-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues.","author":"Swerdlow","year":"2017"},{"issue":"5","key":"2021072015341282800_B18","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1200\/JCO.2006.09.2403","article-title":"Revised response criteria for malignant lymphoma","volume":"25","author":"Cheson","year":"2007","journal-title":"J Clin Oncol."},{"issue":"4","key":"2021072015341282800_B19","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1002\/sim.4067","article-title":"Multiple imputation using chained equations: issues and guidance for practice","volume":"30","author":"White","year":"2011","journal-title":"Stat Med."},{"issue":"3","key":"2021072015341282800_B20","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1158\/1055-9965.EPI-16-0595","article-title":"HIV infection and survival of lymphoma patients in the era of highly active antiretroviral therapy","volume":"26","author":"Han","year":"2017","journal-title":"Cancer Epidemiol Biomarkers Prev."},{"issue":"5","key":"2021072015341282800_B21","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1093\/annonc\/mdv036","article-title":"Changes in the influence of lymphoma- and HIV-specific factors on outcomes in AIDS-related non-Hodgkin lymphoma","volume":"26","author":"Barta","year":"2015","journal-title":"Ann Oncol."},{"issue":"33","key":"2021072015341282800_B22","doi-asserted-by":"crossref","first-page":"4111","DOI":"10.1200\/JCO.2011.41.4193","article-title":"HIV status does not influence outcome in patients with classical Hodgkin lymphoma treated with chemotherapy using doxorubicin, bleomycin, vinblastine, and dacarbazine in the highly active antiretroviral therapy era","volume":"30","author":"Montoto","year":"2012","journal-title":"J Clin Oncol."},{"issue":"5","key":"2021072015341282800_B23","first-page":"704","article-title":"The prognosis of HIV-infected patients with diffuse large B-cell lymphoma treated with chemotherapy and highly active antiretroviral therapy is similar to that of HIV-negative patients receiving chemotherapy","volume":"90","author":"Navarro","year":"2005","journal-title":"Haematologica."},{"issue":"3","key":"2021072015341282800_B24","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1200\/JCO.1996.14.3.925","article-title":"Adults and children with small non-cleaved-cell lymphoma have a similar excellent outcome when treated with the same chemotherapy regimen","volume":"14","author":"Magrath","year":"1996","journal-title":"J Clin Oncol."},{"issue":"4","key":"2021072015341282800_B25","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1080\/1042819031000141301","article-title":"Modified Magrath regimens for adults with Burkitt and Burkitt-like lymphomas: preserved efficacy with decreased toxicity","volume":"45","author":"Lacasce","year":"2004","journal-title":"Leuk Lymphoma."},{"issue":"1","key":"2021072015341282800_B26","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/bjh.17188","article-title":"A dose-dense short-term therapy for human immunodeficiency virus\/acquired immunodeficiency syndrome patients with high-risk Burkitt lymphoma or high-grade B-cell lymphoma: safety and efficacy results of the \u201cCARMEN\u201d phase II trial","volume":"192","author":"Ferreri","year":"2021","journal-title":"Br J Haematol."},{"issue":"20","key":"2021072015341282800_B27","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1056\/NEJMoa1308392","article-title":"Low-intensity therapy in adults with Burkitt\u2019s lymphoma","volume":"369","author":"Dunleavy","year":"2013","journal-title":"N Engl J Med."},{"issue":"15","key":"2021072015341282800_B28","doi-asserted-by":"crossref","first-page":"3008","DOI":"10.1182\/blood-2009-08-231613","article-title":"Rituximab plus concurrent infusional EPOCH chemotherapy is highly effective in HIV-associated B-cell non-Hodgkin lymphoma","volume":"115","author":"Sparano","year":"2010","journal-title":"Blood."},{"key":"2021072015341282800_B29","article-title":"Outcomes of Burkitt lymphoma with central nervous system involvement: evidence from a large multi-center cohort study","author":"Zayac","journal-title":"Haematologica."},{"issue":"6","key":"2021072015341282800_B30","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1080\/10428194.2020.1725505","article-title":"A retrospective study on prephase therapy prior to definitive multiagent chemotherapy in aggressive lymphomas","volume":"61","author":"Malpica","year":"2020","journal-title":"Leuk Lymphoma."},{"issue":"3","key":"2021072015341282800_B31","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1182\/blood-2003-06-2095","article-title":"Two-weekly or 3-weekly CHOP chemotherapy with or without etoposide for the treatment of elderly patients with aggressive lymphomas: results of the NHL-B2 trial of the DSHNHL","volume":"104","author":"Pfreundschuh","year":"2004","journal-title":"Blood."},{"key":"2021072015341282800_B32","first-page":"79","article-title":"Characteristics and outcomes of HIV-related Burkitt lymphoma (HIV-BL) in the post-rituximab era across 30 US cancer centers","volume":"4","author":"Alderuccio","year":"2020","journal-title":"HemaSphere."},{"key":"2021072015341282800_B33","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1182\/blood-2020-136989","article-title":"Prognostication, survival and treatment-related outcomes in HIV-associated Burkitt lymphoma (HIV-BL): a US and UK collaborative analysis","volume":"136","author":"Alderuccio","year":"2020","journal-title":"Blood."}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/5\/14\/2852\/1814209\/advancesadv2021004458.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/5\/14\/2852\/1814209\/advancesadv2021004458.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T00:15:24Z","timestamp":1672877724000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/5\/14\/2852\/476385\/HIV-associated-Burkitt-lymphoma-outcomes-from-a-US"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,20]]},"references-count":33,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2021,7,27]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2021004458","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,20]]}}}